Abstract
To investigate whether Akkermansia muciniphila (A. muciniphila; AKK) affects colitis by regulating the ferroptosis signaling pathway, an mouse model of colitis was constructed, and the mice were administered with A. muciniphila and Erastin (ferroptosis agonist). HE staining and transmission electron microscopy were used to observe the pathological and microstructural changes of mouse colon tissues. The number of goblet cells was examined using alcian blue staining. The expression levels of indicators related to oxidative stress and ferroptosis were detected by ELISA, western blot and immunohistochemisty. Transcriptome and non-targeted metabolome sequencing were carried out to screen for the differentially expressed genes and metabolites. Immunofluorescence double staining was used to detect the co-localization of cell adhesion-related indicators.16S microbiota sequencing was performed on mouse feces. Erastin caused damage to colon tissues, decreased the expression of ZO-1 and E-Cadherin, and increased the expression of indicators related to oxidative stress and ferroptosis. The species-abundance was increased after A. muciniphila treatment, while it was decreased after treatment with A. muciniphila and Erastin. A. muciniphila reduced inflammatory cell infiltration, alleviated organelle damage, and decreased the number of goblet cells in mice with colitis. MDA, ROS, and Fe2+ levels in colitis tissues were increased, but they were decreased after A. muciniphila treatment. The expression of GPX4 and SLC7A11 was decreased, while ACSL4 was increased. A. muciniphila intervention reversed the trend of changes in the above indicators and enriched 19 pathways. In conclusion, A. muciniphila could treat colitis in mice, and its mechanism may be related to the inhibition of the ferroptosis signaling pathway.
Availability of data and material
The data underlying this article will be shared on reasonable request to the corresponding author.
References
Wang, Z. et al. Lactobacillus vaginalis alleviates DSS induced colitis by regulating the gut microbiota and increasing the production of 3-indoleacrylic acid. Pharmacol. Res. 213, 107663 (2025).
Dong, X. Q. et al. Keratin 1 modulates intestinal barrier and immune response via kallikrein kinin system in ulcerative colitis. World J. Gastroenterol. 31, 102070 (2025).
Zhang, Z. et al. Gene expression regulation and polyadenylation in ulcerative colitis via long-chain RNA sequencing. BMC Genomics 26, 147 (2025).
Tan, C. et al. Diosmin alleviates colitis by inhibiting PANoptosis of intestinal epithelial cells and regulating gut microbiota and metabolites. Phytomedicine 141, 156671 (2025).
Yue, N. et al. Real-world of Limosilactobacillus reuteri in mitigation of acute experimental colitis. J. Nanobiotechnol. 23, 65 (2025).
Zheng, M. et al. The role of Akkermansia muciniphila in inflammatory bowel disease: Current knowledge and perspectives. Front Immunol. 13, 1089600 (2023).
Huang, S. et al. Lithium carbonate alleviates colon inflammation through modulating gut microbiota and Treg cells in a GPR43-dependent manner. Pharmacol. Res. 175, 105992 (2022).
Chen, S. et al. Astaxanthin inhibits ferroptosis of hippocampal neurons in kainic acid-induced epileptic mice by activating the Nrf2/GPX4 signaling pathway. CNS Neurosci. Ther. 31, e70238 (2025).
He, X., Liu, Y., Zhou, H. & Wu, K. Intestinal bacterium Akkermansia muciniphila inhibits progression of abdominal aortic aneurysm. Antioxid. Redox Signal. 43, 782–804 (2025).
Lyu, X., Zhang, T. T., Ye, Z. & Chen, C. Astragaloside IV mitigated diabetic nephropathy by restructuring intestinal microflora and ferroptosis. Mol. Nutr. Food Res. 68, e2300734 (2024).
Zhu, K. et al. Iron chelators loaded on myocardiocyte mitochondria-targeted nanozyme system for treating myocardial ischemia-reperfusion injury in mouse models. J. Nanobiotechnol. 23, 112 (2025).
Sealey, D. C. et al. Therapeutic drug monitoring for dose optimization of infliximab in patients with inflammatory bowel disease: An analysis of Canadian real-world data. Can. J. Gastroenterol. Hepatol. 2025, 5713315 (2025).
Chen, Y., Fan, W., Lyu, Y., Liao, J. & Zhou, Y. METTL14 modulates the progression and ferroptosis of colitis by regulating the stability of m6A-modified GPX4. Eur. J. Med. Res. 30, 88 (2025).
Zheng, S. et al. Polydatin protects against DSS-induced ulcerative colitis via Nrf2/Slc7a11/Gpx4-dependent inhibition of ferroptosis signalling activation. Front. Pharmacol. 15, 1513020 (2024).
Zhang, Q. et al. Exploring the potential active components and mechanisms of Tetrastigma hemsleyanum against ulcerative colitis based on network pharmacology in LPS-induced RAW2647 cells. J. Ethnopharmacol. 342, 119384 (2025).
Seril, D. N. et al. Dietary iron supplementation enhances DSS-induced colitis and associated colorectal carcinoma development in mice. Dig. Dis. Sci. 47, 1266–1278 (2002).
Millar, A. D., Rampton, D. S. & Blake, D. R. Effects of iron and iron chelation in vitro on mucosal oxidant activity in ulcerative colitis. Aliment. Pharmacol. Ther. 14, 1163–1168 (2000).
Xu, M. et al. Ferroptosis involves in intestinal epithelial cell death in ulcerative colitis. Cell Death Dis. 11, 86 (2020).
Tilg, H., Adolph, T. E., Gerner, R. R. & Moschen, A. R. The intestinal microbiota in colorectal cancer. Cancer Cell 33, 954–964 (2018).
Wu, Z. et al. Gut microbiota from green tea polyphenol-dosed mice improves intestinal epithelial homeostasis and ameliorates experimental colitis. Microbiome 9, 184 (2021).
Wu, X. et al. The gut microbiota-xanthurenic acid-aromatic hydrocarbon receptor axis mediates the anticolitic effects of trilobatin. Adv. Sci. 12, e2412234 (2025).
Abdullah, S. et al. Gingerols: Preparation, encapsulation, and bioactivities focusing gut microbiome modulation and attenuation of disease symptoms. Phytomed. Int. J. Phytother. Phytopharmacol. 136, 156352 (2025).
Kaser, A. & Blumberg, R. S. Endoplasmic reticulum stress and intestinal inflammation. Mucosal Immunol. 3, 11–16 (2010).
Pu, W. et al. Inhibitory effects of Clostridium butyricum culture and supernatant on inflammatory colorectal cancer in mice. Front. Immunol. 14, 1004756 (2023).
Xu, H., Luo, H., Zhang, J., Li, K. & Lee, M. H. Therapeutic potential of Clostridium butyricum anticancer effects in colorectal cancer. Gut Microbes 15, 2186114 (2023).
Wang, L. et al. A purified membrane protein from Akkermansia muciniphila or the pasteurised bacterium blunts colitis associated tumourigenesis by modulation of CD8(+) T cells in mice. Gut 69, 1988–1997 (2020).
Meynier, M. et al. Pasteurized akkermansia muciniphila improves irritable bowel syndrome-like symptoms and related behavioral disorders in mice. Gut Microbes 16, 2298026 (2024).
Bian, X. et al. Administration of Akkermansia muciniphila ameliorates dextran sulfate sodium-induced ulcerative colitis in mice. Front. Microbiol. 10, 2259 (2019).
Liu, M., Xie, W., Wan, X. & Deng, T. Clostridium butyricum modulates gut microbiota and reduces colitis associated colon cancer in mice. Int. Immunopharmacol. 88, 106862 (2020).
Huang, X. et al. Clostridium butyricum and chitooligosaccharides in synbiotic combination ameliorate symptoms in a DSS-induced ulcerative colitis mouse model by modulating gut microbiota and enhancing intestinal barrier function. Microbiol. Spectrum 11, e0437022 (2023).
Li, W., Zhang, Y., Chen, M., Guo, X. & Ding, Z. The antioxidant strain Lactiplantibacillus plantarum AS21 and Clostridium butyricum ameliorate DSS-induced colitis in mice by remodeling the assembly of intestinal microbiota and improving gut functions. Food Funct. 15, 2022–2037 (2024).
He, K. Y. et al. Akkermansia muciniphila protects the intestine from irradiation-induced injury by secretion of propionic acid. Gut Microbes 15, 2293312 (2023).
Ma, L. et al. Clostridium butyricum and its derived extracellular vesicles modulate gut homeostasis and ameliorate acute experimental colitis. Microbiol. Spectrum 10, e0136822 (2022).
Xi, M. et al. Stachyose increases intestinal barrier through Akkermansia muciniphila and reduces gut inflammation in germ-free mice after human fecal transplantation. Food Res. Int. 137, 109288 (2020).
Li, Z. et al. Study of growth, metabolism, and morphology of Akkermansia muciniphila with an in vitro advanced bionic intestinal reactor. BMC Microbiol. 21, 61 (2021).
Shin, J. et al. Elucidation of Akkermansia muciniphila Probiotic Traits Driven by Mucin Depletion. Front. Microbiol. 10, 1137 (2019).
Funding
This work was supported by Fujian Provincial Health Technology Project (No.2024GGA030); Natural Science Foundation of Fujian Province (No.2024J01574); Startup Fund for Scientific Research of Fujian Medical University (No.2023QH1099).
Author information
Authors and Affiliations
Contributions
L.Z., Y.J.L., K.Y.W., and G.X.G. conceived and designed the project. J.X.W., W.L., and S.H.Z. collected the data. L.Z., Y.J.L., K.Y.W., G.X.G., J.X.W., and G.X.G. analyzed and interpreted the data. Y.J.L. and G.X.G. drafted the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics approval and consent to participate
This study was approved by the Institutional Animal Care and Use Committee of Fujian Medical University.
Consent for publication
All authors approved this manuscript to be published.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Zhang, L., Liu, Y., Wei, K. et al. Akkermansia muciniphila affects colitis by inhibiting ferroptosis signaling pathway. Sci Rep (2026). https://doi.org/10.1038/s41598-026-38452-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-026-38452-4
